Pantheon sold fund stakes at 15% below value to buy its own shares at 21% below
Pantheon International sold 42 fund positions across 28 managers for £224 million in May 2026. It quotes two discounts for the same sale. Against the 30 June 2025 reference value the price was 8.1% below. Against the 31 March 2026 valuations, and inclusive of fees, currency and other costs, it was about 13% to 15% below. It then put at least £180 million of the proceeds into buying back its own shares, trading 21% below net asset value.
Key numbers, and what they mean
8.1% or 15%
The same sale, quoted twice: 8.1% against the 30 June 2025 reference value, and about 13% to 15% against the 31 March 2026 valuations inclusive of fees, currency and other costs. Two things differ between those numbers and Pantheon does not split them.
21% from 40%
Where its own shares traded against net asset value at the end of May 2026, having been 40% below a year earlier. Selling assets at 15% below value to retire claims on them priced 21% below is accretive arithmetic.
£180M
Of the £224 million of proceeds committed to buying back shares, of which £118.4 million was executed within the year and £63.9 million immediately after it.
90 to 62
Manager relationships, from about 90 at the end of November 2025 to 62 on completion of the sale in May 2026, against a target of roughly 25 core managers. The sale removed all 28 at once.
Portfolio by type, after the sale
Fund investments42%
Co-investments37%
Manager-led secondaries21%
Pantheon's own figures for the effect of the sale. Before it, fund exposure was 47%, made up of 39% primaries and 8% fund secondaries, with co-investments at 33% and manager-led secondaries at 20%.
The read-through
From the report
Takeaway: how to apply it to a portfolio
The same sale is quoted at an 8.1% discount to the 30 June 2025 reference value, and at about 13% to 15% against the 31 March 2026 valuations inclusive of fees, currency and other costs.
When a seller gives you two discounts, ask what changed between them. Here two things moved at once: the valuation date shifted forward by nine months, over which the stakes were marked up, and costs were added. Pantheon does not separate the effects, so neither can you.
At least £180 million of the £224 million of proceeds went into buying back shares trading 21% below net asset value at the end of May 2026, and 40% below a year earlier. The board describes investing in its own portfolio at a discount as a highly attractive opportunity.
The discount you accept on an exit only matters against what you do with the money. Selling assets at 13% to 15% below value in order to retire claims on those same assets priced 21% or more below value is accretive. Price the exit and the redeployment together, never separately.
Forty-two positions across 28 managers sold in one auction, 24 of them already classified as non-core, with the roster falling from about 90 to 62 against a target of roughly 25.
If a quarter of your managers are ones you would not back again, you do not have a portfolio, you have an archive. Classify each relationship core or non-core now and let the non-core ones run off by not re-upping. That costs nothing. Selling them as a block does not.
The Argus lensPantheon quotes its exit at 8.1% and at 13% to 15%, against different valuation dates and different cost assumptions, without splitting them. Knowing which mark a price is struck against, and what a quoted number leaves out, is exactly the read we give you.
Benchmark your deals in the Portal →
About the source
Pantheon International's announcement of the sale in May 2026 and its annual results for the year ended 31 May 2026 give the 42 positions, the 28 managers, the £224 million of net proceeds, both discount figures, the buyback commitment and the manager count. The annual results state the second discount as measured against valuations at 31 March 2026 and inclusive of fees, currency and other costs. The portfolio composition shown is Pantheon's own projection of the effect of the sale.